Safi Bio

Developer of developing cell therapies from hematopoietic progenitor cells

placeBoston, Massachusetts, United States calendar_todayFounded 2019 groups7 employees language safi.bio

Social engagement

Social engagement: 1.2K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record; lead investors include J2 Ventures.

Investor typeCountShare
Venture capital1100%

Recent activity

31 Mar 2026
Partnership
DesiCorp Inc
4 Feb 2026
Partnership
Safi
8 Jan 2026
Milestone
regulatory
Coming soon